{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:15:10Z","timestamp":1783484110548,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04900-8","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:55:06Z","timestamp":1778885706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Navigating false-positive outcomes after stool-based colorectal cancer screening tests: a scoping review"],"prefix":"10.1186","volume":"26","author":[{"given":"Amal","family":"Cheema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7486-8310","authenticated-orcid":false,"given":"Audrey H.","family":"Calderwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"19","key":"4900_CR1","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2021.6238","volume":"325","author":"KW Davidson","year":"2021","unstructured":"Davidson KW, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965\u201377.","journal-title":"JAMA"},{"issue":"19","key":"4900_CR2","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2021.5746","volume":"325","author":"AB Knudsen","year":"2021","unstructured":"Knudsen AB, et al. Colorectal cancer screening: an updated modeling study for the US Preventive Services Task Force. JAMA. 2021;325(19):1998\u20132011.","journal-title":"JAMA"},{"key":"4900_CR3","doi-asserted-by":"publisher","unstructured":"Rivero-S\u00e1nchez L, et al. Colorectal cancer after negative colonoscopy in fecal immunochemical test-positive participants from a colorectal cancer screening program. Endosc Int Open. Sep. 2018;6(9):E1140\u20138. https:\/\/doi.org\/10.1055\/a-0650-4296.","DOI":"10.1055\/a-0650-4296"},{"key":"4900_CR4","doi-asserted-by":"crossref","unstructured":"de Klaver W, van der Vlugt M, Spaander MC, Bossuyt PM, Dekker E. Risk of cancers proximal to the colon in fecal immunochemical test positive screenees in a colorectal cancer screening program. Gastroenterology. 2024;167(4):788\u201397.","DOI":"10.1053\/j.gastro.2024.04.028"},{"issue":"10","key":"4900_CR5","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1002\/ijc.31972","volume":"144","author":"EL Amitay","year":"2019","unstructured":"Amitay EL, Cuk K, Niedermaier T, Weigl K, Brenner H. Factors associated with false-positive fecal immunochemical tests in a large German colorectal cancer screening study. Int J Cancer. 2019;144(10):2419\u201327.","journal-title":"Int J Cancer"},{"issue":"9","key":"4900_CR6","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s00384-021-03947-1","volume":"36","author":"M Domper Arnal","year":"2021","unstructured":"Domper Arnal M, et al. False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use. Int J Colorectal Dis. 2021;36(9):1861\u20139.","journal-title":"Int J Colorectal Dis"},{"key":"4900_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00535-020-01738-z","volume":"56","author":"G Ib\u00e1\u00f1ez-Sanz","year":"2021","unstructured":"Ib\u00e1\u00f1ez-Sanz G, et al. Proton-pump inhibitors are associated with a high false-positivity rate in faecal immunochemical testing. J Gastroenterol. 2021;56:42\u201353.","journal-title":"J Gastroenterol"},{"issue":"2","key":"4900_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/MCG.0000000000000588","volume":"51","author":"NH Kim","year":"2017","unstructured":"Kim NH, Park JH, Park DI, Sohn CI, Choi K, Jung YS. Risk factors for false fecal immunochemical test results in colorectal cancer screening. J Clin Gastroenterol. 2017;51(2):151\u20139.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"4900_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/codi.16886","volume":"26","author":"L\u00d8 Hansen","year":"2024","unstructured":"Hansen L\u00d8, F\u00fcrst MB, Bj\u00f8rsum-Meyer T, Schelde-Olesen B, Deding U, Kaalby L. Factors associated with negative colonoscopy in participants with a positive faecal immunochemical test from the Danish Colorectal Cancer Screening Program \u2013 a population-based study. Colorectal Dis. 2024;26(3):476\u201385. https:\/\/doi.org\/10.1111\/codi.16886.","journal-title":"Colorectal Dis"},{"issue":"7","key":"4900_CR10","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.3390\/jcm9072172","volume":"9","author":"YS Jung","year":"2020","unstructured":"Jung YS, Lee J, Moon CM. Positive fecal immunochemical test results are associated with increased risks of esophageal, stomach, and small intestine cancers. J Clin Med. 2020;9(7):2172.","journal-title":"J Clin Med"},{"key":"4900_CR11","doi-asserted-by":"publisher","unstructured":"Zhou MJ, Singh G, Hwang JH, Ladabaum U. Risk of Proximal Gastrointestinal Cancer After Positive Fecal Immunochemical Test. Clin Gastroenterol Hepatol. Nov. 2023;21(12):3179\u201381. https:\/\/doi.org\/10.1016\/j.cgh.2022.11.032.","DOI":"10.1016\/j.cgh.2022.11.032"},{"issue":"6","key":"4900_CR12","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.gie.2023.02.013","volume":"97","author":"A Shah","year":"2023","unstructured":"Shah A, et al. Upper GI endoscopy in subjects with positive fecal occult blood test undergoing colonoscopy: systematic review and meta-analysis. Gastrointest Endosc. 2023;97(6):1005\u201315.","journal-title":"Gastrointest Endosc"},{"key":"4900_CR13","doi-asserted-by":"publisher","unstructured":"Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. Nov. 2018;18:143. https:\/\/doi.org\/10.1186\/s12874-018-0611-x.","DOI":"10.1186\/s12874-018-0611-x"},{"issue":"7","key":"4900_CR14","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/gutjnl-2020-320761","volume":"70","author":"S-M Peng","year":"2021","unstructured":"Peng S-M, et al. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme. Gut. 2021;70(7):1318\u201324.","journal-title":"Gut"},{"issue":"05","key":"4900_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1055\/a-2230-5563","volume":"56","author":"PH Wisse","year":"2024","unstructured":"Wisse PH, et al. Post-colonoscopy colorectal cancers in a national fecal immunochemical test-based colorectal cancer screening program. Endoscopy. 2024;56(05):364\u201372.","journal-title":"Endoscopy"},{"key":"4900_CR16","doi-asserted-by":"publisher","unstructured":"Tricco AC, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. Oct. 2018;169(7):467\u201373. https:\/\/doi.org\/10.7326\/M18-0850.","DOI":"10.7326\/M18-0850"},{"key":"4900_CR17","doi-asserted-by":"publisher","unstructured":"Ng JY, Chan DKH, Tan KK. Is gastroscopy for fecal immunochemical test positive patients worthwhile? Int J Colorectal Dis. Jan. 2017;32(1):95\u20138. https:\/\/doi.org\/10.1007\/s00384-016-2666-7.","DOI":"10.1007\/s00384-016-2666-7"},{"issue":"4","key":"4900_CR18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1158\/1055-9965.EPI-16-0800","volume":"26","author":"TG Cotter","year":"2017","unstructured":"Cotter TG, et al. Long-term follow-up of patients having false-positive multitarget stool DNA tests after negative screening colonoscopy: the LONG-HAUL cohort study. Cancer Epidemiol Biomarkers Prev. 2017;26(4):614\u201321.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"4900_CR19","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.dld.2016.06.011","volume":"48","author":"G Ib\u00e1\u00f1ez-Sanz","year":"2016","unstructured":"Ib\u00e1\u00f1ez-Sanz G, et al. Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening. Dig Liver Disease. 2016;48(10):1249\u201354.","journal-title":"Dig Liver Disease"},{"issue":"4","key":"4900_CR20","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.cgh.2019.07.057","volume":"18","author":"BM Berger","year":"2020","unstructured":"Berger BM, et al. Low incidence of aerodigestive cancers in patients with negative results from colonoscopies, regardless of findings from multitarget stool DNA tests. Clin Gastroenterol Hepatol. 2020;18(4):864\u201371.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"4900_CR21","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s10620-018-5001-z","volume":"63","author":"GS Cooper","year":"2018","unstructured":"Cooper GS, et al. Evaluation of patients with an apparent false positive stool DNA test: the role of repeat stool DNA testing. Dig Dis Sci. 2018;63(6):1449\u201353.","journal-title":"Dig Dis Sci"},{"issue":"12","key":"4900_CR22","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1111\/jgh.16799","volume":"39","author":"S Pakneshan","year":"2024","unstructured":"Pakneshan S, et al. Post-colonoscopy upper gastrointestinal malignancies in positive immunochemical fecal occult blood test patients: An Australian data linkage study. J Gastroenterol Hepatol. 2024;39(12):2811\u20136.","journal-title":"J Gastroenterol Hepatol"},{"key":"4900_CR23","doi-asserted-by":"crossref","unstructured":"van der Vlugt M, et al. Risk of oral and upper gastrointestinal cancers in persons with positive results from a fecal immunochemical test in a colorectal cancer screening program. Clin Gastroenterol Hepatol. 2018;16(8):1237\u201343.e2.","DOI":"10.1016\/j.cgh.2018.01.037"},{"key":"4900_CR24","doi-asserted-by":"publisher","first-page":"102309","DOI":"10.1016\/j.pmedr.2023.102309","volume":"35","author":"LF Butterly","year":"2023","unstructured":"Butterly LF, Hisey WM, Robinson CM, Limburg PJ, Kneedler BL, Anderson JC. What do \u2018false-positive\u2019stool tests really mean? Data from the New Hampshire colonoscopy registry. Prev Med Rep. 2023;35:102309.","journal-title":"Prev Med Rep"},{"issue":"2","key":"4900_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1155\/2010\/516363","volume":"24","author":"J Allard","year":"2010","unstructured":"Allard J, Cosby R, Del Giudice ME, Irvine EJ, Morgan D, Tinmouth J. Gastroscopy following a positive fecal occult blood test and negative colonoscopy: systematic review and guideline. Can J Gastroenterol Hepatol. 2010;24(2):113\u201320.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"4900_CR26","doi-asserted-by":"publisher","first-page":"1653617","DOI":"10.3389\/or.2025.1653617","volume":"19","author":"M Sapienza","year":"2025","unstructured":"Sapienza M, Davis C, Boudes M. Navigating the evolving landscape of colorectal cancer screening with a practical framework: a comprehensive analysis of existing and emerging technologies for informed decision-making. Oncol Reviews. 2025;19:1653617.","journal-title":"Oncol Reviews"},{"issue":"11","key":"4900_CR27","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1056\/NEJMoa2310336","volume":"390","author":"TF Imperiale","year":"2024","unstructured":"Imperiale TF, et al. Next-generation multitarget stool DNA test for colorectal cancer screening. N Engl J Med. 2024;390(11):984\u201393.","journal-title":"N Engl J Med"},{"issue":"12","key":"4900_CR28","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1055\/a-2136-6564","volume":"55","author":"HJ van de Schootbrugge-Vandermeer","year":"2023","unstructured":"van de Schootbrugge-Vandermeer HJ, et al. Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program. Endoscopy. 2023;55(12):1061\u20139.","journal-title":"Endoscopy"},{"issue":"5","key":"4900_CR29","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s10620-021-06986-4","volume":"67","author":"JS Hunt","year":"2022","unstructured":"Hunt JS, Cock C, Symonds EL. A true positive and a false negative? The dilemma of negative colonoscopy after a positive fecal occult blood test. Dig Dis Sci. 2022;67(5):1843\u20139.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"4900_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10620-024-08748-4","volume":"70","author":"KS Liu","year":"2025","unstructured":"Liu KS, et al. Interval Advanced Adenomas and Neoplasia in Patients with Negative Colonoscopy Following Positive Stool-Based Colorectal Cancer Screening Test. Dig Dis Sci. 2025;70(1):350\u20139.","journal-title":"Dig Dis Sci"},{"key":"4900_CR31","doi-asserted-by":"crossref","unstructured":"Butterly LF, Hisey WM, Robinson CM, Kneedler BL, Anderson JC. Association of endoscopist colonoscopy quality measures with follow-up colonoscopy outcomes after positive stool tests (Multitarget Stool DNA or Fecal Immunochemical Test): retrospective cross-sectional analysis of data from the New Hampshire Colonoscopy Registry. Am J Gastroenterol. 2024;119(11):2215\u201323.","DOI":"10.14309\/ajg.0000000000002817"},{"key":"4900_CR32","unstructured":"Rex DK et al. Quality Indicators for Colonoscopy, Official journal of the American College of Gastroenterology | ACG, vol. 119, no. 9, 2024. Available: https:\/\/journals.lww.com\/ajg\/fulltext\/2024\/09000\/quality_indicators_for_colonoscopy.14.aspx."},{"key":"4900_CR33","doi-asserted-by":"publisher","unstructured":"Qaseem A et al. Aug., Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians (Version 2), Ann Intern Med, vol. 176, no. 8, pp. 1092\u20131100, 2023, https:\/\/doi.org\/10.7326\/M23-0779.","DOI":"10.7326\/M23-0779"},{"key":"4900_CR34","doi-asserted-by":"publisher","unstructured":"Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG Clinical Guidelines: Colorectal Cancer Screening 2021, Am J Gastroenterol, vol. 116, no. 3, pp. 458\u2013479, Mar. 2021, https:\/\/doi.org\/10.14309\/ajg.0000000000001122.","DOI":"10.14309\/ajg.0000000000001122"},{"key":"4900_CR35","doi-asserted-by":"publisher","unstructured":"Augustus GJ, Ellis NA. Colorectal Cancer Disparity in African Americans: Risk Factors and Carcinogenic Mechanisms. Am J Pathol. Feb. 2018;188(2):291\u2013303. https:\/\/doi.org\/10.1016\/j.ajpath.2017.07.023.","DOI":"10.1016\/j.ajpath.2017.07.023"},{"issue":"16","key":"4900_CR36","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1001\/jama.2017.3634","volume":"317","author":"DA Corley","year":"2017","unstructured":"Corley DA, et al. Association between time to colonoscopy after a positive fecal test result and risk of colorectal cancer and cancer stage at diagnosis. JAMA. 2017;317(16):1631\u201341.","journal-title":"JAMA"},{"key":"4900_CR37","first-page":"2809","volume":"21","author":"M Denters","year":"2013","unstructured":"Denters M, Deutekom M, Essink-Bot M, Bossuyt P, Fockens P, Dekker E. FIT false-positives in colorectal cancer screening experience psychological distress up to 6 weeks after colonoscopy. Support Care Cancer. 2013;21:2809\u201315.","journal-title":"Support Care Cancer"},{"issue":"2","key":"4900_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/02813432.2019.1608040","volume":"37","author":"EL Toft","year":"2019","unstructured":"Toft EL, Kaae SE, Malmqvist J, Brodersen J. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study. Scand J Prim Health Care. 2019;37(2):145\u201354.","journal-title":"Scand J Prim Health Care"},{"issue":"4","key":"4900_CR39","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cgh.2019.10.016","volume":"18","author":"DJ Robertson","year":"2020","unstructured":"Robertson DJ, Dominitz JA. When results from multitarget DNA tests are positive and colonoscopy is negative, should we be concerned about cancer outside the colon? Clin Gastroenterol Hepatol. 2020;18(4):783\u20136.","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04900-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04900-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04900-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:40:00Z","timestamp":1783482000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04900-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4900"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04900-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. As the review did not involve primary data or analysis of individual data from human subjects, no ethics review nor consent to participant was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"422"}}